Itamar Medical Ltd. provided preliminary unaudited revenue guidance for the fourth quarter and full year ended December 31, 2019 and revenue guidance for the full year 2020. Total revenue for the fourth quarter of 2019 is expected to be $9.6 to $9.8 million, an increase of 46% to 49% compared to $6.6 million in the same quarter in 2018. Total revenue for the full year ended December 31, 2019 is expected to be $31.1 to $31.3 million, an increase of 29% compared to $24.2 million in 2018. Full year 2020 revenue is expected to be in the range of approximately $39.5 million to $42.0 million, reflecting growth of approximately 26% to 35% over full year 2019 preliminary revenue of $31.1 to $31.3 million.